Precursor T-cell lymphoblastic leukemia
Precursor T-cell lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia that affects T cells. It is characterized by the rapid growth of immature white blood cells known as lymphoblasts. T-ALL is a rare form of cancer, accounting for approximately 15% of all cases of acute lymphoblastic leukemia.
Etiology[edit | edit source]
The exact cause of T-ALL is unknown. However, it is believed to be caused by a combination of genetic and environmental factors. Some studies have suggested that exposure to certain chemicals or radiation may increase the risk of developing T-ALL.
Pathophysiology[edit | edit source]
In T-ALL, the bone marrow produces too many immature lymphocytes, which are a type of white blood cell. These immature cells, known as lymphoblasts, are unable to function properly and can crowd out healthy cells in the bone marrow, leading to a variety of symptoms.
Clinical Presentation[edit | edit source]
Patients with T-ALL often present with symptoms such as fatigue, fever, and unexplained weight loss. Other symptoms may include bone pain, swollen lymph nodes, and frequent infections due to a weakened immune system.
Diagnosis[edit | edit source]
Diagnosis of T-ALL typically involves a complete blood count (CBC), bone marrow biopsy, and cytogenetic analysis. Additional tests may be performed to determine the specific subtype of T-ALL and to guide treatment decisions.
Treatment[edit | edit source]
Treatment for T-ALL typically involves chemotherapy, with the goal of achieving complete remission. In some cases, stem cell transplantation may be considered. The specific treatment plan will depend on a variety of factors, including the patient's age, overall health, and the specific characteristics of the leukemia.
Prognosis[edit | edit source]
The prognosis for T-ALL varies widely and depends on a variety of factors, including the patient's age, overall health, and response to treatment. With modern treatment strategies, many patients with T-ALL are able to achieve long-term remission.
See Also[edit | edit source]
 | This hematology article is a stub. You can help WikiMD by expanding it. |
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
